• In recent months, Chewy has been highlighted for expanding its Autoship subscription program and moving into physical veterinary clinics through acquisitions such as Modern Animal, while its CEO executed a pre-planned sale of a small portion of his holdings.
• This combination of deeper recurring revenue efforts and a push into higher-margin vet services is reshaping how investors assess Chewy’s business mix and resilience.
• Next, we’ll examine how Chewy’s push into brick-and-mortar vet clinics could alter its investment narrative and long-term revenue profile.

Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.

Chewy Investment Narrative Recap

To own Chewy, you need to believe its Autoship-heavy e-commerce model and newer vet services can support consistent, profitable growth despite a volatile share-price history and premium valuation. The latest headlines around Autoship expansion, brick-and-mortar vet clinics, and the CEO’s pre-planned stock sale do not materially alter the key near term story, which still centers on whether Chewy can improve profitability while reigniting active customer growth.

The most relevant recent development is Chewy’s push into physical veterinary clinics through deals like Modern Animal. This move sits at the heart of the current catalyst: using vet services to deepen customer relationships and open up higher margin revenue streams beyond pet supplies. At the same time, it touches a key risk, since any underperformance from these clinics could blunt the expected boost to margins and weaken the case for Chewy’s current valuation.

Yet beneath this expansion, there is an important risk around Chewy’s heavy reliance on Autoship that investors should be aware of if subscription habits start to...

Chewy's narrative projects $15.7 billion revenue and $569.8 million earnings by 2029. This requires 6.8% yearly revenue growth and roughly a $314.6 million earnings increase from $255.2 million today.

Uncover how Chewy's forecasts yield a $31.05 fair value, a 32% upside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already cautious, assuming revenue of about US$15.4 billion and earnings of roughly US$411 million by 2029, and the new Autoship and vet clinic news could either challenge that more pessimistic view or reinforce concerns that growth and margins might fall short of what you expect.

Explore 5 other fair value estimates on Chewy - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Chewy research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Chewy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chewy's overall financial health at a glance.

Want Some Alternatives?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.